Clinical trial • Oncology

Clinical trial in Hepatocellular carcinoma

Clinical trial for Hepatocellular carcinoma. 40 participants.

Overview

Trial Therapeutic Area
Oncology
Trial Disease
Hepatocellular carcinoma
Drug Modality
Radiopharmaceutical|Diagnostic agent

Key dates

Initial CTIS Submission Date
11-02-2025
First CTIS Authorization Date
06-05-2025

Trial design

Clinical trial across 4 sites in France.

Target Sample Size
40
Trial Duration For Participant
730

Recruitment

Planned Sample Size
40
Recruitment Window Months
24

Geography

Total Number Of Sites
4
Total Number Of Participants
40

France

Earliest CTIS Part Ii Submission Date
14-04-2025
Latest Decision Or Authorization Date
06-05-2025
Processing Time Days
22
Number Of Sites
4
Number Of Participants
40

Sites

Site Name
Centre Hospitalier Universitaire De Nantes
Department Name
Nuclear Medecine
Principal Investigator Name
Clément BAILLY
Principal Investigator Email
clement.bailly@chu-nantes.fr
Contact Person Name
Clément BAILLY
Contact Person Email
clement.bailly@chu-nantes.fr
Site Name
Hopital Beaujon
Department Name
Gastro-entérologie et hépatologie
Principal Investigator Name
Mohamed BOUATTOUR
Principal Investigator Email
mohamed.bouattour@aphp.fr
Contact Person Name
Mohamed BOUATTOUR
Contact Person Email
mohamed.bouattour@aphp.fr
Site Name
Centre Hospitalier Universitaire De Nantes
Department Name
Institut des Maladies de l’Appareil Digestif
Principal Investigator Name
Yann TOUCHEFEU
Principal Investigator Email
yann.touchefeu@chu-nantes.fr
Contact Person Name
Yann TOUCHEFEU
Contact Person Email
yann.touchefeu@chu-nantes.fr
Site Name
Hopital Beaujon
Department Name
Nuclear Medecine
Principal Investigator Name
Rachida LEBTAHI
Principal Investigator Email
rachida.lebtahi@aphp.fr
Contact Person Name
Rachida LEBTAHI
Contact Person Email
rachida.lebtahi@aphp.fr

Sponsor

Primary sponsor

Full Name
Centre Hospitalier Universitaire De Nantes
Organisation Type
Hospital/Clinic/Other health care facility
Country Of Registered Address
France

Related trials

Other published trials that may interest you.